Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 4;16(6):e0252378.
doi: 10.1371/journal.pone.0252378. eCollection 2021.

Metabolomic profiling of microbial disease etiology in community-acquired pneumonia

Affiliations

Metabolomic profiling of microbial disease etiology in community-acquired pneumonia

Ilona den Hartog et al. PLoS One. .

Abstract

Diagnosis of microbial disease etiology in community-acquired pneumonia (CAP) remains challenging. We undertook a large-scale metabolomics study of serum samples in hospitalized CAP patients to determine if host-response associated metabolites can enable diagnosis of microbial etiology, with a specific focus on discrimination between the major CAP pathogen groups S. pneumoniae, atypical bacteria, and respiratory viruses. Targeted metabolomic profiling of serum samples was performed for three groups of hospitalized CAP patients with confirmed microbial etiologies: S. pneumoniae (n = 48), atypical bacteria (n = 47), or viral infections (n = 30). A wide range of 347 metabolites was targeted, including amines, acylcarnitines, organic acids, and lipids. Single discriminating metabolites were selected using Student's T-test and their predictive performance was analyzed using logistic regression. Elastic net regression models were employed to discover metabolite signatures with predictive value for discrimination between pathogen groups. Metabolites to discriminate S. pneumoniae or viral pathogens from the other groups showed poor predictive capability, whereas discrimination of atypical pathogens from the other groups was found to be possible. Classification of atypical pathogens using elastic net regression models was associated with a predictive performance of 61% sensitivity, 86% specificity, and an AUC of 0.81. Targeted profiling of the host metabolic response revealed metabolites that can support diagnosis of microbial etiology in CAP patients with atypical bacterial pathogens compared to patients with S. pneumoniae or viral infections.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow chart of the formation of the three studied patient groups.
Fig 2
Fig 2. Schematic representation of stratified nested cross-validation for elastic net regression model optimization and performance [21].
Abbreviations: CV: cross-validation.
Fig 3
Fig 3. ROC curves of the results from logistic regression and elastic net regression models that were tested in five-fold cross-validation with 100 repeats for the comparisons: atypical versus S. pneumoniae and viral pathogens; S. pneumoniae pathogens versus atypical and viral pathogens; and viral versus S. pneumoniae and atypical pathogens.
Abbreviations: LR: logistic regression, EN: elastic net regression, SDMA: symmetric dimethylarginine, LPI (18:1): lysophosphatidylinositol (18:1).
Fig 4
Fig 4. Variable importance of metabolites for the prediction of an atypical bacterial infection versus S. pneumoniae and viral infections.
Only metabolites with an absolute mean percentage of influence > 1% are visualized.

References

    1. Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K, et al.. Outcome of community-acquired pneumonia: Influence of age, residence status and antimicrobial treatment. Eur Respir J. 2008. Jul 1;32(1):139–46. doi: 10.1183/09031936.00092507 - DOI - PubMed
    1. Meijvis SCA, Hardeman H, Remmelts HHF, Heijligenberg R, Rijkers GT, Van Velzen-Blad H, et al.. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: A randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9782):2023–30. doi: 10.1016/S0140-6736(11)60607-7 - DOI - PubMed
    1. Endeman H, Schelfhout V, Paul Voorn G, van Velzen-Blad H, Grutters JC, Biesma DH. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis. 2008. Jan 8;40(9):715–20. doi: 10.1080/00365540802014864 - DOI - PubMed
    1. Wunderink RG, Waterer GW. Community-Acquired Pneumonia. Solomon CG, editor. N Engl J Med. 2014. Feb 6;370(6):543–51. doi: 10.1056/NEJMcp1214869 - DOI - PubMed
    1. Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, et al.. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Neth J Med. 2018;76(1). - PubMed

Publication types

MeSH terms

LinkOut - more resources